Evidence map›Paper›PMID 42645363›Full record

ArticleCurrent oncology (Toronto, Ont.)2026

Older Age Does Not Have an Impact on Postoperative Complication Risk Following Transurethral Resection of the Bladder Tumor.

Minami Une, Shinya Yamamoto, Honoka Fuse, Yusuke Yoneoka, Kenjiro Noda

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Minami UneDepartment of Urology, Nishitokyo Chuo General Hospital, Tokyo 188-0014, Japan.
Shinya YamamotoDepartment of Urology, Nishitokyo Chuo General Hospital, Tokyo 188-0014, Japan.
Honoka FuseDepartment of Urology, Nishitokyo Chuo General Hospital, Tokyo 188-0014, Japan.
Yusuke YoneokaDepartment of Urology, Nishitokyo Chuo General Hospital, Tokyo 188-0014, Japan.
Kenjiro NodaDepartment of Urology, Nishitokyo Chuo General Hospital, Tokyo 188-0014, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThe incidence of bladder cancer has been increasing within the aging population. Transurethral resection of bladder tumor (TURBT) is the first-line treatment for bladder cancer, serving both diagnostic and therapeutic purposes. In this study, we aimed to investigate the incidence and predictors of postoperative complications following TURBT in a general hospital with a high proportion of older patients.

methodsWe analyzed 141 Japanese patients retrospectively who had undergone TURBT for clinically diagnosed bladder cancer between January 2018 and December 2023. Postoperative complications occurring within 30 days were reviewed from medical records, and risk factors were evaluated.

resultsPostoperative complications were observed in 49 patients (34.8%), with 28 patients (20%) classified as Clavien-Dindo grade I and 21 (15%) as grade II or higher. In univariable analysis, factors significantly associated with postoperative complications included older age (odds ratio [OR]: 1.04;

conclusionsTURBT appears feasible in older patients when performed by experienced surgeons. Age alone should not be considered a limiting factor for surgical eligibility.

Indexed as

Postoperative ComplicationsTransurethral Resection of BladderUrinary Bladder NeoplasmsAgedAged, 80 and overAge FactorsFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Factorsagebladder cancerolder patientspostoperative complicationsrisk factorstransurethral resection of bladder tumor (TURBT)

Identifiers

PMID42645363
PMCPMC13511190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.